Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense Oligonucleotide Therapies Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Without GalNAc-conjugated
1.2.3 With GalNAc-conjugated
1.3 Market by Application
1.3.1 Global Antisense Oligonucleotide Therapies Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Genetic Disease
1.3.3 Cancer
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antisense Oligonucleotide Therapies Market Perspective (2018-2034)
2.2 Antisense Oligonucleotide Therapies Growth Trends by Region
2.2.1 Global Antisense Oligonucleotide Therapies Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Antisense Oligonucleotide Therapies Historic Market Size by Region (2018-2023)
2.2.3 Antisense Oligonucleotide Therapies Forecasted Market Size by Region (2024-2034)
2.3 Antisense Oligonucleotide Therapies Market Dynamics
2.3.1 Antisense Oligonucleotide Therapies Industry Trends
2.3.2 Antisense Oligonucleotide Therapies Market Drivers
2.3.3 Antisense Oligonucleotide Therapies Market Challenges
2.3.4 Antisense Oligonucleotide Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense Oligonucleotide Therapies Players by Revenue
3.1.1 Global Top Antisense Oligonucleotide Therapies Players by Revenue (2018-2023)
3.1.2 Global Antisense Oligonucleotide Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Antisense Oligonucleotide Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antisense Oligonucleotide Therapies Revenue
3.4 Global Antisense Oligonucleotide Therapies Market Concentration Ratio
3.4.1 Global Antisense Oligonucleotide Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense Oligonucleotide Therapies Revenue in 2024
3.5 Antisense Oligonucleotide Therapies Key Players Head office and Area Served
3.6 Key Players Antisense Oligonucleotide Therapies Product Solution and Service
3.7 Date of Enter into Antisense Oligonucleotide Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense Oligonucleotide Therapies Breakdown Data by Type
4.1 Global Antisense Oligonucleotide Therapies Historic Market Size by Type (2018-2023)
4.2 Global Antisense Oligonucleotide Therapies Forecasted Market Size by Type (2024-2034)
5 Antisense Oligonucleotide Therapies Breakdown Data by Application
5.1 Global Antisense Oligonucleotide Therapies Historic Market Size by Application (2018-2023)
5.2 Global Antisense Oligonucleotide Therapies Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Antisense Oligonucleotide Therapies Market Size (2018-2034)
6.2 North America Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Antisense Oligonucleotide Therapies Market Size by Country (2018-2023)
6.4 North America Antisense Oligonucleotide Therapies Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antisense Oligonucleotide Therapies Market Size (2018-2034)
7.2 Europe Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Antisense Oligonucleotide Therapies Market Size by Country (2018-2023)
7.4 Europe Antisense Oligonucleotide Therapies Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense Oligonucleotide Therapies Market Size (2018-2034)
8.2 Asia-Pacific Antisense Oligonucleotide Therapies Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2018-2023)
8.4 Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antisense Oligonucleotide Therapies Market Size (2018-2034)
9.2 Latin America Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Antisense Oligonucleotide Therapies Market Size by Country (2018-2023)
9.4 Latin America Antisense Oligonucleotide Therapies Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense Oligonucleotide Therapies Market Size (2018-2034)
10.2 Middle East & Africa Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2018-2023)
10.4 Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ionis Pharmaceuticals
11.1.1 Ionis Pharmaceuticals Company Detail
11.1.2 Ionis Pharmaceuticals Business Overview
11.1.3 Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Introduction
11.1.4 Ionis Pharmaceuticals Revenue in Antisense Oligonucleotide Therapies Business (2018-2023)
11.1.5 Ionis Pharmaceuticals Recent Development
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Detail
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics Antisense Oligonucleotide Therapies Introduction
11.2.4 Sarepta Therapeutics Revenue in Antisense Oligonucleotide Therapies Business (2018-2023)
11.2.5 Sarepta Therapeutics Recent Development
11.3 Nippon Shinyaku
11.3.1 Nippon Shinyaku Company Detail
11.3.2 Nippon Shinyaku Business Overview
11.3.3 Nippon Shinyaku Antisense Oligonucleotide Therapies Introduction
11.3.4 Nippon Shinyaku Revenue in Antisense Oligonucleotide Therapies Business (2018-2023)
11.3.5 Nippon Shinyaku Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antisense Oligonucleotide Therapies Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Without GalNAc-conjugated
Table 3. Key Players of With GalNAc-conjugated
Table 4. Global Antisense Oligonucleotide Therapies Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Antisense Oligonucleotide Therapies Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Antisense Oligonucleotide Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Antisense Oligonucleotide Therapies Market Share by Region (2018-2023)
Table 8. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Antisense Oligonucleotide Therapies Market Share by Region (2024-2034)
Table 10. Antisense Oligonucleotide Therapies Market Trends
Table 11. Antisense Oligonucleotide Therapies Market Drivers
Table 12. Antisense Oligonucleotide Therapies Market Challenges
Table 13. Antisense Oligonucleotide Therapies Market Restraints
Table 14. Global Antisense Oligonucleotide Therapies Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Antisense Oligonucleotide Therapies Market Share by Players (2018-2023)
Table 16. Global Top Antisense Oligonucleotide Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotide Therapies as of 2024)
Table 17. Ranking of Global Top Antisense Oligonucleotide Therapies Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Antisense Oligonucleotide Therapies Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Antisense Oligonucleotide Therapies Product Solution and Service
Table 21. Date of Enter into Antisense Oligonucleotide Therapies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antisense Oligonucleotide Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Antisense Oligonucleotide Therapies Revenue Market Share by Type (2018-2023)
Table 25. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Antisense Oligonucleotide Therapies Revenue Market Share by Type (2024-2034)
Table 27. Global Antisense Oligonucleotide Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Antisense Oligonucleotide Therapies Revenue Market Share by Application (2018-2023)
Table 29. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Antisense Oligonucleotide Therapies Revenue Market Share by Application (2024-2034)
Table 31. North America Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Antisense Oligonucleotide Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Antisense Oligonucleotide Therapies Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Antisense Oligonucleotide Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Antisense Oligonucleotide Therapies Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Antisense Oligonucleotide Therapies Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Antisense Oligonucleotide Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Antisense Oligonucleotide Therapies Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2024-2034) & (US$ Million)
Table 46. Ionis Pharmaceuticals Company Detail
Table 47. Ionis Pharmaceuticals Business Overview
Table 48. Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Product
Table 49. Ionis Pharmaceuticals Revenue in Antisense Oligonucleotide Therapies Business (2018-2023) & (US$ Million)
Table 50. Ionis Pharmaceuticals Recent Development
Table 51. Sarepta Therapeutics Company Detail
Table 52. Sarepta Therapeutics Business Overview
Table 53. Sarepta Therapeutics Antisense Oligonucleotide Therapies Product
Table 54. Sarepta Therapeutics Revenue in Antisense Oligonucleotide Therapies Business (2018-2023) & (US$ Million)
Table 55. Sarepta Therapeutics Recent Development
Table 56. Nippon Shinyaku Company Detail
Table 57. Nippon Shinyaku Business Overview
Table 58. Nippon Shinyaku Antisense Oligonucleotide Therapies Product
Table 59. Nippon Shinyaku Revenue in Antisense Oligonucleotide Therapies Business (2018-2023) & (US$ Million)
Table 60. Nippon Shinyaku Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antisense Oligonucleotide Therapies Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Antisense Oligonucleotide Therapies Market Share by Type: 2024 VS 2034
Figure 3. Without GalNAc-conjugated Features
Figure 4. With GalNAc-conjugated Features
Figure 5. Global Antisense Oligonucleotide Therapies Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Antisense Oligonucleotide Therapies Market Share by Application: 2024 VS 2034
Figure 7. Genetic Disease Case Studies
Figure 8. Cancer Case Studies
Figure 9. Cardiovascular Diseases Case Studies
Figure 10. Other Case Studies
Figure 11. Antisense Oligonucleotide Therapies Report Years Considered
Figure 12. Global Antisense Oligonucleotide Therapies Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Antisense Oligonucleotide Therapies Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Antisense Oligonucleotide Therapies Market Share by Region: 2024 VS 2034
Figure 15. Global Antisense Oligonucleotide Therapies Market Share by Players in 2024
Figure 16. Global Top Antisense Oligonucleotide Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotide Therapies as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Antisense Oligonucleotide Therapies Revenue in 2024
Figure 18. North America Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Antisense Oligonucleotide Therapies Market Share by Country (2018-2034)
Figure 20. United States Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Antisense Oligonucleotide Therapies Market Share by Country (2018-2034)
Figure 24. Germany Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Antisense Oligonucleotide Therapies Market Share by Region (2018-2034)
Figure 32. China Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Antisense Oligonucleotide Therapies Market Share by Country (2018-2034)
Figure 40. Mexico Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Antisense Oligonucleotide Therapies Market Share by Country (2018-2034)
Figure 44. Turkey Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Antisense Oligonucleotide Therapies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Ionis Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotide Therapies Business (2018-2023)
Figure 47. Sarepta Therapeutics Revenue Growth Rate in Antisense Oligonucleotide Therapies Business (2018-2023)
Figure 48. Nippon Shinyaku Revenue Growth Rate in Antisense Oligonucleotide Therapies Business (2018-2023)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed